2-(3-IOdophenyl)-2,3-dihydro-1h-naphtho[1,8-de][1,3,2]diazaborinine

Catalog No. :
ACDWDF501
CAS No. :
2724208-15-3
Molecular Formula :
C16H12BIN2
Molecular Weight :
370.00

IUPAC Name:2-(3-iodophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine

2-(3-IOdophenyl)-2,3-dihydro-1h-naphtho[1,8-de][1,3,2]diazaborinine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$136.00Login to see priceInquiryInquiry
1g97%$330.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-IOdophenyl)-2,3-dihydro-1h-naphtho[1,8-de][1,3,2]diazaborinine
IUPAC Name2-(3-iodophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine
MDL No.MFCD20527127
Molecular FormulaC16H12BIN2
Molecular Weight370.00
SMILESIC1=CC=CC(=C1)B1NC2=CC=CC3=C2C(N1)=CC=C3
InChI KeyQJXIPDWLWOMOGB-UHFFFAOYSA-N
Synonym1H-Naphtho[1,8-de]-1,3,2-diazaborine, 2,3-dihydro-2-(3-iodophenyl)-;2,3-Dihydro-2-(3-iodophenyl)-1H-naphtho[1,8-de]-1,3,2-diazaborine
CAS No.2724208-15-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDWDF501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQIZU029 route compound structure diagram
    ACQIZU029591-18-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDWDF501 route product structure diagram
    ACDWDF5012724208-15-3
Inquiry

2. ACDWDF501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJUOY387 route compound structure diagram
    ACJUOY387626-00-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDWDF501 route product structure diagram
    ACDWDF5012724208-15-3
Inquiry

Comments (0)